Publication | Closed Access
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells
177
Citations
13
References
2005
Year
MedicineReceptor Tyrosine KinasePharmacologyAnti-cancer AgentCancer TreatmentOncologyCell BiologyTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1